Clinical Trial Update: Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of a 3-month formulation of triptorelin in Chinese children with central precocious puberty has completed. Re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Precocious Puberty

Drugs mentioned

• Triptorelin (triptorelin)

Snippet

Sponsor: Ipsen | Conditions: Central Precocious Puberty | Phase 3 | Status: COMPLETED | Results posted: 2024-08-01